{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:57:53Z","timestamp":1792839473213,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.blre.2016.05.003","type":"journal-article","created":{"date-parts":[[2016,5,29]],"date-time":"2016-05-29T01:06:38Z","timestamp":1464483998000},"page":"431-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications"],"prefix":"10.1016","volume":"30","author":[{"given":"Martine","family":"Regenboog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 B.P.","family":"van Kuilenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine W.","family":"Swinkels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2016.05.003_bb0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides. Evidence of an enzymatic deficiency in Gaucher's disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.blre.2016.05.003_bb0010","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2016.05.003_bb0015","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"Gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.blre.2016.05.003_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcmd.2010.10.007","article-title":"A monozygotic twin pair with highly discordant Gaucher phenotypes","volume":"46","author":"Biegstraaten","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0010021","article-title":"Enzyme replacement in Gaucher disease","volume":"1","author":"Beutler","year":"2004","journal-title":"PLoS Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0035","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2016.05.003_bb0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bcmd.2014.04.002","article-title":"Eliglustat, an investigational oral therapy for Gaucher disease type 1: phase 2 trial results after 4years of treatment","volume":"53","author":"Lukina","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0045","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","article-title":"Long-term clinical outcomes in type 1 Gaucher disease following 10years of imiglucerase treatment","volume":"36","author":"Weinreb","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-014-0112-x","article-title":"Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications","volume":"9","author":"van Dussen","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1210\/jc.2007-1702","article-title":"Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance","volume":"93","author":"Langeveld","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.blre.2016.05.003_bb0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10545-010-9070-1","article-title":"High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease","volume":"33","author":"Taddei","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0070","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0075","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/brain\/awq198","article-title":"Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study","volume":"133","author":"Biegstraaten","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.blre.2016.05.003_bb0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bjh.12335","article-title":"Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature","volume":"161","author":"Arends","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2016.05.003_bb0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1615\/CritRevOncog.2013005921","article-title":"Causes of death due to hematological and non-hematological cancers in 57 US patients with type 1 Gaucher disease who were never treated with enzyme replacement therapy","volume":"18","author":"Weinreb","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.blre.2016.05.003_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients","volume":"84","author":"Taddei","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2016.05.003_bb0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-2005-871201","article-title":"Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature","volume":"25","author":"Xu","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0105","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1021\/bi300752r","article-title":"Mechanisms of mammalian iron homeostasis","volume":"51","author":"Pantopoulos","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.blre.2016.05.003_bb0110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00204-010-0577-x","article-title":"Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples","volume":"84","author":"Kell","year":"2010","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.blre.2016.05.003_bb0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nrm2295","article-title":"Regulation of iron acquisition and storage: consequences for iron-linked disorders","volume":"9","author":"De Domenico","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.blre.2016.05.003_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2012.04.002","article-title":"Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment","volume":"49","author":"Mekinian","year":"2012","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21721","article-title":"Hyperferritinemia and iron overload in type 1 Gaucher disease","volume":"85","author":"Stein","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2016.05.003_bb0130","first-page":"657","article-title":"Plasma ferritin determination as a diagnostic tool","volume":"145","author":"Finch","year":"1986","journal-title":"West J Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0135","first-page":"760","article-title":"Serum ferritin: past, present and future","volume":"2010","author":"Wang","year":"1800","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.blre.2016.05.003_bb0140","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cmet.2015.09.006","article-title":"Ironing out ferroportin","volume":"22","author":"Drakesmith","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.blre.2016.05.003_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2005-923315","article-title":"Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis","volume":"25","author":"Ramm","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0150","series-title":"The online metabolic & molecular bases of inherited disease","article-title":"Gaucher disease","author":"Grabowski","year":"2010"},{"key":"10.1016\/j.blre.2016.05.003_bb0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-53-2-293","article-title":"The occurrence of intracellular iron in Gaucher's disease","volume":"53","author":"Lorber","year":"1960","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0002-9343(67)90070-8","article-title":"Gaucher's disease. A morphologic study and measurements of iron metabolism","volume":"42","author":"Lee","year":"1967","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000209069","article-title":"Identification of ferritin within gaucher cells. An electron microscopic and immunofluorescent study","volume":"37","author":"Lorber","year":"1967","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2016.05.003_bb0170","first-page":"404","article-title":"Adult type Gaucher's disease: a secondary disorder of iron metabolism","volume":"37","author":"Lorber","year":"1970","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0175","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2013-08-524447","article-title":"To the editor: resolution of thrombocytopenia with JAK2 mutation in a patient with Gaucher disease","volume":"122","author":"Amato","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.05.003_bb0180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1084\/jem.16.6.797","article-title":"A contribution to the pathology of primary splenomegaly (Gaucher type), with the report of an autopsy on a male child four and one half years of age","volume":"16","author":"Mandlebaum","year":"1912","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0185","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/bmj.1.5749.590","article-title":"Gaucher's disease in mother and daughter","volume":"1","author":"Sood","year":"1971","journal-title":"Br Med J"},{"key":"10.1016\/j.blre.2016.05.003_bb0190","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1365-2141.2003.04695.x","article-title":"Cytochemical diagnosis of Gaucher's disease by iron stain","volume":"124","author":"Weisberger","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2016.05.003_bb0195","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ajh.23537","article-title":"Novel G377S (c.1246G>T) mutation associated with Gaucher disease type 1","volume":"88","author":"Zhou","year":"2013","journal-title":"Am J Hematol."},{"key":"10.1016\/j.blre.2016.05.003_bb0200","first-page":"131","article-title":"Immunohistochemical and ultrastructural features of Gaucher's cells\u2014five case reports","volume":"55","author":"Bogoeva","year":"2001","journal-title":"Acta Med Croatica"},{"key":"10.1016\/j.blre.2016.05.003_bb0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2000-9419","article-title":"Perinatal lethal form of Gaucher's disease presenting with hemosiderosis","volume":"17","author":"Sharma","year":"2000","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.blre.2016.05.003_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00188091","article-title":"The application of laser microprobe mass analysis to the study of biological material","volume":"9","author":"Iancu","year":"1996","journal-title":"Biometals"},{"key":"10.1016\/j.blre.2016.05.003_bb0215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.blre.2016.05.003_bb0220","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0950-3536(97)80034-0","article-title":"Plasma and metabolic abnormalities in Gaucher's disease","volume":"10","author":"Aerts","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.blre.2016.05.003_bb0225","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/bmj.286.6381.1864","article-title":"Serum ferritin concentration in Gaucher's disease","volume":"286","author":"Morgan","year":"1983","journal-title":"Br Med J"},{"key":"10.1016\/j.blre.2016.05.003_bb0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0953-6205(03)00038-4","article-title":"Hyperferritinemia revealing Gaucher's disease","volume":"14","author":"Decaux","year":"2003","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0235","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.clinbiochem.2011.05.016","article-title":"Biomarkers in Serbian patients with Gaucher disease","volume":"44","author":"Sumarac","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.blre.2016.05.003_bb0240","first-page":"589","article-title":"Ferritins: a family of molecules for iron storage, antioxidation and more","volume":"2009","author":"Arosio","year":"1790","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.blre.2016.05.003_bb0245","doi-asserted-by":"crossref","first-page":"1549S","DOI":"10.1093\/jn\/133.5.1549S","article-title":"Ferritin: at the crossroads of iron and oxygen metabolism","volume":"133","author":"Theil","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.blre.2016.05.003_bb0250","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.05.003_bb0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.blre.2016.05.003_bb0260","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1297-319X(02)00409-8","article-title":"Ferritin levels in adult Still's disease: any sugar?","volume":"69","author":"Fautrel","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.blre.2016.05.003_bb0265","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease","volume":"28","author":"Fautrel","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.blre.2016.05.003_bb0270","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcmd.2010.10.014","article-title":"Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease","volume":"46","author":"Stirnemann","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Rosario","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.blre.2016.05.003_bb0285","first-page":"788","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease","volume":"2007","author":"van Breemen","year":"1772","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.blre.2016.05.003_bb0290","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2016.05.003_bb0295","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2016.05.003_bb0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bcmd.2014.07.007","article-title":"Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease","volume":"53","author":"Medrano-Engay","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2016.05.003_bb0305","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0891-5849(00)00319-1","article-title":"Acidic pH amplifies iron-mediated lipid peroxidation in cells","volume":"28","author":"Schafer","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0310","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00418-008-0394-y","article-title":"Lysosomes in iron metabolism, ageing and apoptosis","volume":"129","author":"Kurz","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.blre.2016.05.003_bb0315","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.biocel.2011.08.016","article-title":"The role of lysosomes in iron metabolism and recycling","volume":"43","author":"Kurz","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.blre.2016.05.003_bb0320","first-page":"1291","article-title":"Lysosomes and oxidative stress in aging and apoptosis","volume":"2008","author":"Kurz","year":"1780","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.blre.2016.05.003_bb0325","doi-asserted-by":"crossref","first-page":"C445","DOI":"10.1152\/ajpcell.00505.2005","article-title":"Release of iron from ferritin requires lysosomal activity","volume":"291","author":"Kidane","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.blre.2016.05.003_bb0330","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.blre.2016.05.003_bb0335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphar.2014.00045","article-title":"Labile iron in cells and body fluids: physiology, pathology, and pharmacology","volume":"5","author":"Cabantchik","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.blre.2016.05.003_bb0340","first-page":"403","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"2012","author":"Brissot","year":"1820","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.blre.2016.05.003_bb0345","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3324\/haematol.2015.133983","article-title":"Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders","volume":"101","author":"de Swart","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2016.05.003_bb0350","first-page":"151","article-title":"Survey of hematological aspects of Gaucher disease","volume":"10","author":"Zimran","year":"2005","journal-title":"Hematol (Amsterdam, Neth)"},{"key":"10.1016\/j.blre.2016.05.003_bb0355","first-page":"3085","article-title":"Splenectomy in Gaucher disease: new management dilemmas","volume":"91","author":"Krasnewich","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.05.003_bb0360","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5years of treatment: a report from the gaucher registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2016.05.003_bb0365","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cyto.b.20539","article-title":"A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis","volume":"80","author":"Bratosin","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.blre.2016.05.003_bb0370","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2016.05.003_bb0375","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/eji.200939889","article-title":"Differential regulation of iron homeostasis during human macrophage polarized activation","volume":"40","author":"Recalcati","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.blre.2016.05.003_bb0380","doi-asserted-by":"crossref","first-page":"18975","DOI":"10.1074\/jbc.R115.650150","article-title":"Regulation of iron metabolism by hepcidin under conditions of inflammation","volume":"290","author":"Schmidt","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2016.05.003_bb0385","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/pbc.24373","article-title":"GDF15-mediated upregulation of ferroportin plays a key role in the development of hyperferritinemia in children with hemophagocytic lymphohistiocytosis","volume":"60","author":"Wu","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2016.05.003_bb0390","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2014-05-516252","article-title":"Molecular liaisons between erythropoiesis and iron metabolism","volume":"124","author":"Kautz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.05.003_bb0395","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2015-07-658419","article-title":"Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia","volume":"126","author":"Kautz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.05.003_bb0400","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuint.2012.11.015","article-title":"Genetics and iron in the systems biology of Parkinson's disease and some related disorders","volume":"62","author":"Funke","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.blre.2016.05.003_bb0405","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevOncog.2013006145","article-title":"Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism","volume":"18","author":"Mistry","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.blre.2016.05.003_bb0410","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.gastro.2004.09.019","article-title":"Iron, hemochromatosis, and hepatocellular carcinoma","volume":"127","author":"Kowdley","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.blre.2016.05.003_bb0415","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ajh.2830180407","article-title":"Interaction between a serum factor and T lymphocytes in Gaucher disease","volume":"18","author":"Bassan","year":"1985","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2016.05.003_bb0420","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2337\/diabetes.51.8.2348","article-title":"Cross-talk between iron metabolism and diabetes","volume":"51","author":"Fernandez-Real","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.blre.2016.05.003_bb0425","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1016\/S0021-9258(19)84438-1","article-title":"Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane","volume":"261","author":"Davis","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2016.05.003_bb0430","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00262217","article-title":"Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?","volume":"26","author":"Niederau","year":"1984","journal-title":"Diabetologia"},{"key":"10.1016\/j.blre.2016.05.003_bb0435","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s001250051667","article-title":"Oxidative stress impairs insulin internalization in endothelial cells in vitro","volume":"44","author":"Bertelsen","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.blre.2016.05.003_bb0440","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/j.seminhematol.2009.06.001","article-title":"Iron sequestration and anemia of inflammation","volume":"46","author":"Ganz","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2016.05.003_bb0445","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood-2002-04-1260","article-title":"Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease","volume":"100","author":"Weinstein","year":"2002","journal-title":"Blood"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T20:33:11Z","timestamp":1656621191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X16300285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0268960X16300285"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2016.05.003","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2016.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}